Palbociclib

Palbociclib is a type of targeted cancer drug. It is also known as Ibrance.

You pronounce palbociclib as pal-boh-sye-klib.

It is a treatment for breast cancer that is oestrogen receptor positive (ER+) and human epidermal growth factor receptor negative (HER2 -).

You might have palbociclib if your breast cancer has spread to:

• the area and structures surrounding the breast, such as nearby lymph nodes, muscle and skin, but not to other parts of the body (locally advanced)

• another part of the body (advanced or metastatic breast cancer)

You usually have palbociclib in combination with a hormone therapy drug.